Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial

Autor: Yhim, H.-Y., Kim, T., Kim, S.J., Shin, H.-J., Koh, Y., Kim, J.S., Park, J., Park, G.S., Kim, W.S., Moon, J.H., Yang, D.-H.
Zdroj: In Annals of Oncology April 2021 32(4):552-559
Databáze: ScienceDirect